Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec;26(12):1413-1425.
doi: 10.1007/s11886-024-02137-z. Epub 2024 Sep 24.

Innovations in Imaging: 18F-Fluorodeoxyglucose PET/CT for Assessment of Cardiovascular Infection and Inflammation

Affiliations
Review

Innovations in Imaging: 18F-Fluorodeoxyglucose PET/CT for Assessment of Cardiovascular Infection and Inflammation

Siddharth J Trivedi et al. Curr Cardiol Rep. 2024 Dec.

Abstract

Purpose of review: 18F-Fluorodeoxyglucose positron emission tomography (PET) combined with computed tomography (CT), referred to as 18F-FDG PET/CT, plays a significant role in the diagnosis and management of patients with systemic infectious and inflammatory conditions. This review provides an overview of 18F-FDG PET/CT in systemic infectious and inflammatory conditions, including infective endocarditis (IE), cardiac implantable electrical device (CIED)/left ventricular assist device (LVAD) infection, sarcoidosis, and large-vessel vasculitis (LVV).

Recent findings: This review highlights the past and present literature in the increasing role of 18F-FDG PET/CT in cardiovascular inflammation and infection, including diagnostic and prognostic findings. They key aspects of this paper are to highlight the importance of 18F-FDG PET/CT in cardiovascular infection and inflammation, and to provide illustrations of how it can contribute to patient diagnosis and management.

Keywords: 18F-FDG; Cardiac Imaging; Cardiovascular Infection; Inflammation; Nuclear Cardiology; PET/CT.

PubMed Disclaimer

Conflict of interest statement

Declarations. Human and Animal Rights and Informed Consent: This article does not contain any studies with human or animal subjects performed by any of the authors. Conflict of Interest: Dr Bourque consults for GE Healthcare consulting. The other authors report no conflicts.

Figures

Fig. 1
Fig. 1
Aortic prosthetic valve infective endocarditis. A 52-year-old female presented with fever and bacteremia in the context of a mechanical aortic valve. A 18F-fluorodeoxyglucose (18F-FDG) PET/CT imaging study was acquired, obtaining images from the vertex of the skull through the toes, followed by a dedicated cardiac bed acquisition. Fusion and PET images are displayed, images A and B correspond to the axial plane, images C and D correspond to the coronal plane, and images D and E are images oriented to the aortic valve plane. There is intense semi-concentric uptake along the ring of the mechanic aortic valve, higher along the left portion of the valve, concerning for mechanical aortic valve infective endocarditis (white arrows on fusion images and black arrows on PET images). Additionally, there is increased bone marrow and splenic uptake, most likely related to the underlying inflammatory/infectious systemic process (white asterisks on images C and D)
Fig. 2
Fig. 2
CIED pocket and lead infection diagnosed by 18F-FDG PET/CT. Coronal PET images (panel A) show multiple areas of focal, heterogeneous, intense 18F-FDG uptake surrounding the ICD generator (standardized uptake value, SUVmax 4.8, red arrow), along the ICD leads (SUVmax 6, green arrow) and associated with the ICD leads in the right atrium (SUVmax 5.9, blue arrow). Uptake persisted on non-attenuation corrected images (not shown). Fusion with CT (panel B) confirm the anatomic localization. These findings confirmed CIED deep pocket infection with lead involvement. (Adapted from Bourque et al. Journal of Nuclear Cardiology. 2024(34):101786, with permission from Elsevier) [6]
Fig. 3
Fig. 3
Serial 18F-FDG PET/CT imaging to diagnose cardiac sarcoidosis and assess response to therapy. A 67-year-old female with a history of pulmonary sarcoidosis presents with an episode of paroxysmal ventricular tachycardia after three weeks of dyspnea on exertion and orthopnea. She underwent positron emission tomography/computed tomography with 18F-fluorodeoxyglucose (FDG) to assess inflammation and 13N-ammonia to evaluate perfusion (A). Imaging revealed a high concern for active inflammation from cardiac sarcoidosis with prominent heterogeneous 18F-FDG uptake in the apical to basal anteroseptum, inferoseptum, and inferior walls and associated perfusion defect in the same territory. She was started on prednisone and transitioned to mycophenolate mofetil and heart failure goal-directed medical therapy. She had resolution of her symptoms. Repeat imaging at 3 months showed complete resolution of her 18F-FDG uptake consistent with disease remission (B). She was able to taper off therapy successfully
Fig. 4
Fig. 4
Active large vessel vasculitis. A 63-year-old female with a recent diagnosis of giant cell arteritis had an 18F-fluorodeoxyglucose (18F-FDG) PET/CT performed to assess for extent/activity of disease elsewhere. A Vasculitis FDG PET/CT was performed from vertex of the skull through the mid thighs, with a dedicated head and neck bed acquisition. Panel 1: Fusion and PET images are displayed, images A and B correspond to the axial plane at the level of ascending and descending aorta, while images C and D are oriented to the thoracoabdominal aorta. There is concentric FDG uptake along all the segments of the aorta (Images A-D, white arrows on fusion images and black arrows on PET images), consistent with active vasculitis. Panel 2: Fusion and PET images of the head and neck are displayed, images E and F correspond to the axial plane at the level of common carotid arteries, while images G and H correspond to the coronal plane. There is abnormal FDG uptake along the common carotid arteries (Images E-H, white arrows on fusion images and black arrows on PET images), consistent with active vasculitis of the common carotid arteries in the context of known giant cell arteritis

Similar articles

Cited by

References

    1. Robinson AA, Bourque JM. Emerging techniques for Cardiovascular PET. Cardiovasc Innov Appl. 2019;4(1):13–24. - PMC - PubMed
    1. Bourque JM, Einstein AJ, Dorbala S. ASNC Imaging Indications (ASNC-I(2)): Multisocietal indications for radionuclide imaging in the multimodality context-series rationale and methodology. J Nucl Cardiol. 2022;29(5):2667–78. - PubMed
    1. Dorbala S, Cuddy S, Falk RH. How to Image Cardiac Amyloidosis. JACC: Cardiovasc Imaging. 2020;13(6):1368–83. - PMC - PubMed
    1. Ghanem-Zoubi N. FDG PET/CT in Cardiac infection: does it Matter? A narrative review. Infect Dis Therapy. 2022;11(5):1769–77. - PMC - PubMed
    1. Leibovici-Weissman Y, Tau N, Yahav D. Bloodstream infections in the elderly: what is the real goal? Aging Clin Exp Res. 2021;33(4):1101–12. - PubMed
Key references
    1. Wang TKM, Sánchez-Nadales A, Igbinomwanhia E, Cremer P, Griffin B, Xu B. Diagnosis of infective endocarditis by subtype using (18)F-Fluorodeoxyglucose positron emission tomography/computed tomography: a contemporary meta-analysis. Circ Cardiovasc Imaging 2020;13(6):e010600. This meta-analysis evaluated the diagnostic performance of 18F-FDG PET/CT for infective endocarditis and its subtypes. - PubMed
    1. Mahmood M, Kendi AT, Farid S, Ajmal S, Johnson GB, Baddour LM, et al. Role of (18)F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: A meta-analysis. J Nucl Cardiol. 2019;26(3):958–970. This meta-analysis assessed the diagnostic utility of 18F-FDG PET/CT in cardiovascular implantable electronic device (CIED) infections. - PubMed
    1. Divakaran S. Radionuclide Assessment of Sarcoidosis. Cardiol Clin. 2023;41(2):207–215. This review provides an overview of the role of 18F-FDG PET/CT in patients with suspected or known cardiac sarcoidosis. - PubMed
    1. Ahlman MA, Grayson PC. Advanced molecular imaging in large-vessel vasculitis: adopting FDG-PET into a clinical workflow. Best Pract Res Clin Rheumatol. 2023:101856. This review highlights the role of 18F-FDG PET/CT in the diagnosis and monitoring of patients with large vessel vasculitis (LVV). - PMC - PubMed

MeSH terms

Substances